A Phase 2, Open-Label, Randomized, Parallel Group, Placebo-Controlled, Single-Center Study to Assess Anti-microbial Efficacy and Safety of DCN01 Compared to Unisol® Following Topical Periocular Administration in Healthy Volunteers

Completed · Phase 2

Conditions studied: Ocular Infection

In brief

This proof-of-concept study evaluates the clinical efficacy and safety of DCN01 in prepping of the periocular region.

Key facts

Study ID

NCT01853722

Run by

Deacon Biosciences, Inc.

People needed

62

Starts

2013-04-01

Expected to finish

2013-07-01

Last updated by the study team

2016-02-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Have given a written, informed consent
• Be willing and able to follow all instructions
• A negative urine pregnancy test if female of childbearing potential

You may not qualify if…

• Known sensitivities to study medication or its components
• Any signs of an active infection
• Use of disallowed products during the period indicated prior to the enrollment or during the study
• Be currently pregnant, nursing, or planning a pregnancy; or be a woman that has a positive pregnancy test
• Have a condition or a situation which, in the Investigator's opinion, may put the subject at increased risk, confound study data, or interfere significantly with the subject's study participation

Where it is running

• Andover Eye Associates — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.